Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab
Guardado en:
Autor principal: | Yusuf Karabulut |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
AVES Yayincilik
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c5a9f448c174214bd042736c275b8b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biologic treatments in Behçet’s disease
por: Fatma Alibaz-Öner, et al.
Publicado: (2021) -
Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
por: Thomsen SF, et al.
Publicado: (2015) -
Neuro-Behçet: differential diagnosis of recurrent meningitis
por: Fonseca Cardoso,Andreya, et al.
Publicado: (2013) -
Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
por: Sara Salvador-Martín, et al.
Publicado: (2021) -
Acute necrotizing pancreatitis as a manifestation of Behcet’s Disease: A case report and review of the literature
por: Geilan A. Mahmoud, et al.
Publicado: (2022)